Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Liver Diseases

Free Subscription 11.06.2018 2 Am J Gastroenterol 2 Am J Pathol 1 Ann Intern Med 2 Biochem Biophys Res Commun 2 BMC Cancer 1 BMC Gastroenterol 1 Cancer Res 2 Dig Dis Sci 1 Endoscopy 1 Eur Radiol 2 Gastroenterology 1 Gastrointest Endosc 1 Hepatology 1 Int J Cancer 7 J Gastroenterol Hepatol 5 J Hepatol 1 J Pediatr Surg 2 Lancet 2 Lancet Oncol 1 Oncogene 1 Radiology 2 Semin Liver Dis

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Gastroenterol

1. BAJAJ JS, Acharya C, Fagan A, White MB, et al
   Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.
   Am J Gastroenterol. 2018 Jun 6. pii: 10.1038/s41395-018-0085.
   PubMed     Text format     Abstract available
   
   
2. LAI JC, Tandon P
   How I Approach It: Improving Nutritional Status in Patients With Cirrhosis.
   Am J Gastroenterol. 2018 Jun 5. pii: 10.1038/s41395-018-0080.
   PubMed     Text format    
   
   

   
   Am J Pathol

3. DUARTE S, Matian P, Ma S, Busuttil RW, et al
   Adeno-Associated Virus-Mediated Gene Transfer of Tissue Inhibitor of Metalloproteinases-1 Impairs Neutrophil Extracellular Trap Formation and Ameliorates Hepatic Ischemia and Reperfusion Injury.
   Am J Pathol. 2018 Jun 2. pii: S0002-9440(18)30029.
   PubMed     Text format     Abstract available
   
   
4. WANG J, Kainrad N, Shen H, Zhou Z, et al
   Hepatic Knockdown of Splicing Regulator Slu7 Ameliorates Inflammation and Attenuates Liver Injury in Ethanol-Fed Mice.
   Am J Pathol. 2018 Jun 2. pii: S0002-9440(18)30158.
   PubMed     Text format     Abstract available
   
   

   
   Ann Intern Med

5. HAGHIGHAT L, Brandt EJ, Proctor DD, Garcia-Tsao G, et al
   Evolution of Intrahepatic Shunts in a Patient With Hereditary Hemorrhagic Telangiectasia.
   Ann Intern Med. 2018 Jun 5. pii: 2683644. doi: 10.7326/L18-0036.
   PubMed     Text format    
   
   

   
   Biochem Biophys Res Commun

6. FAN XD, Zheng HB, Fan XS, Lu S, et al
   Increase of SOX9 promotes hepatic ischemia/reperfusion (IR) injury by activating TGF-beta1.
   Biochem Biophys Res Commun. 2018 Jun 4. pii: S0006-291X(18)31311.
   PubMed     Text format     Abstract available
   
   
7. XUE X, Wang X, Zhao Y, Hu R, et al
   Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2/TP53INP1/CDKN1A.
   Biochem Biophys Res Commun. 2018 Jun 4. pii: S0006-291X(18)31299.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

8. NG L, Chow AKM, Man JHW, Yau TCC, et al
   Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3beta/beta-catenin pathway.
   BMC Cancer. 2018;18:621.
   PubMed     Text format     Abstract available
   
   
9. HATOOKA M, Kawaoka T, Aikata H, Inagaki Y, et al
   Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial.
   BMC Cancer. 2018;18:633.
   PubMed     Text format     Abstract available
   
   

   
   BMC Gastroenterol

10. MARMUR J, Beshara S, Eggertsen G, Onelov L, et al
    Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
    BMC Gastroenterol. 2018;18:78.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

11. HILL MA, Alexander WB, Guo B, Kato Y, et al
    Kras and Tp53 mutations cause cholangiocyte- and hepatocyte-derived cholangiocarcinoma.
    Cancer Res. 2018 Jun 5. pii: 0008-5472.CAN-17-1123.
    PubMed     Text format     Abstract available
    
    

    
    Dig Dis Sci

12. KOK B, Lester ELW, Lee WM, Hanje AJ, et al
    Acute Liver Failure from Tumor Necrosis Factor-alpha Antagonists: Report of Four Cases and Literature Review.
    Dig Dis Sci. 2018;63:1654-1666.
    PubMed     Text format     Abstract available
    
    
13. TSIAOUSSIS GI, Papaioannou EC, Kourea EP, Assimakopoulos SF, et al
    Expression of alpha-Defensins, CD20+ B-lymphocytes, and Intraepithelial CD3+ T-lymphocytes in the Intestinal Mucosa of Patients with Liver Cirrhosis: Emerging Mediators of Intestinal Barrier Function.
    Dig Dis Sci. 2018 Jun 7. pii: 10.1007/s10620-018-5146.
    PubMed     Text format     Abstract available
    
    

    
    Endoscopy

14. OGURA T, Okuda A, Miyano A, Kamiyama R, et al
    Double intrahepatic bile duct puncture: a pitfall during endoscopic ultrasound-guided hepaticogastrostomy.
    Endoscopy. 2018 Jun 7. doi: 10.1055/a-0605-2710.
    PubMed     Text format    
    
    

    
    Eur Radiol

15. SONG J, Ma Z, Huang J, Liu S, et al
    Comparison of three cut-offs to diagnose clinically significant portal hypertension by liver stiffness in chronic viral liver diseases: a meta-analysis.
    Eur Radiol. 2018 Jun 1. pii: 10.1007/s00330-018-5478.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

16. CHUNG HH
    The Multiple Modulation of miR-122 in the Attenuation of Alcoholic Liver Disease.
    Gastroenterology. 2018;154:1857.
    PubMed     Text format    
    
    
17. GUILLAUME M, Bureau C
    Should the Presence of Spontaneous Portosystemic Shunts Be Implemented to the Model for End-Stage Liver Disease Score for a Better Prediction of Outcome?
    Gastroenterology. 2018;154:1569-1571.
    PubMed     Text format    
    
    

    
    Gastrointest Endosc

18. OH D, Seo DW, Hong SM, Jun JH, et al
    The usefulness of contrast-enhanced harmonic EUS-guided fine-needle aspiration for evaluation of hepatic lesions (with video).
    Gastrointest Endosc. 2018 May 31. pii: S0016-5107(18)32751.
    PubMed     Text format     Abstract available
    
    

    
    Hepatology

19. RUSSO N, Brown RS Jr, Cohen-Mekelburg S, Schwartz RE, et al
    Hepatology Highlights.
    Hepatology. 2018;67:2065-2067.
    PubMed     Text format    
    
    

    
    Int J Cancer

20. ARAI J, Goto K, Tanoue Y, Ito S, et al
    Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells.
    Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31615.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol Hepatol

21. LIU T, Xu L, Wang C, Chen K, et al
    Shikonin alleviates hepatic fibrosis and autophagy via inhibition of TGF-beta1/Smads pathway.
    J Gastroenterol Hepatol. 2018 Jun 4. doi: 10.1111/jgh.14299.
    PubMed     Text format     Abstract available
    
    
22. DONG XQ, Li J, Liu H, Wang YW, et al
    Hepatobiliary and Pancreatic: A rare cause of decompensated liver cirrhosis.
    J Gastroenterol Hepatol. 2018 Jun 3. doi: 10.1111/jgh.14273.
    PubMed     Text format    
    
    
23. MATSUI N, Imajo K, Yoneda M, Kessoku T, et al
    Magnetic resonance elastography increases usefulness and safety of non-invasive screening for esophageal varices.
    J Gastroenterol Hepatol. 2018 Jun 4. doi: 10.1111/jgh.14298.
    PubMed     Text format     Abstract available
    
    
24. MANNAMI T, Fujiwara N, Ikeda G, Ebara H, et al
    Hepatobiliary and Pancreatic: A pancreatic stone causing biliary obstruction through major papillary impaction.
    J Gastroenterol Hepatol. 2018;33:1166.
    PubMed     Text format    
    
    
25. LIN YX, Fu YY, Cui T, Jia QB, et al
    Hepatobiliary and Pancreatic: Alpha fetoprotein producing distal cholangiocarcinoma metastasized to the ovary.
    J Gastroenterol Hepatol. 2018;33:1167.
    PubMed     Text format    
    
    
26. DUAN X, Meng Q, Wang C, Liu Z, et al
    Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice.
    J Gastroenterol Hepatol. 2018;33:533-542.
    PubMed     Text format     Abstract available
    
    
27. PARENTE DB, Oliveira Neto JA, Brasil PEAA, Paiva FF, et al
    Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes.
    J Gastroenterol Hepatol. 2018;33:511-517.
    PubMed     Text format     Abstract available
    
    

    
    J Hepatol

28. LEE S, Kang TW
    Reply to "Influence of ablation technique on treatment failure for perivascular hepatocellular carcinoma".
    J Hepatol. 2018 Jun 2. pii: S0168-8278(18)32117.
    PubMed     Text format    
    
    
29. SUNDARAM V, Goldberg DS, Jalan R
    Author response: Is obesity a risk factor for the development of acute on chronic liver failure in patients with decompensated cirrhosis?
    J Hepatol. 2018 May 31. pii: S0168-8278(18)32100.
    PubMed     Text format    
    
    
30. NAKAMURA K, Zhang M, Kageyama S, Ke B, et al
    Protective effects of heme oxygenase 1 during ischemia r epefrfsuion injury: Hepatocytes or non parenchymal cells?
    J Hepatol. 2018 Jun 2. pii: S0168-8278(18)32114.
    PubMed     Text format    
    
    
31. SEGERITZ CP, Rashid ST, Cardoso de Brito M, Paola MS, et al
    hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in alpha1-antitrypsin deficiency.
    J Hepatol. 2018 Jun 4. pii: S0168-8278(18)32113.
    PubMed     Text format     Abstract available
    
    
32. TURCO L, Garcia-Tsao G, Rossi R, Villa E, et al
    Reply to "The Relationship of Hyperdynamic Circulation and Cardiodynamic States in Cirrhosis".
    J Hepatol. 2018 Jun 2. pii: S0168-8278(18)32101.
    PubMed     Text format    
    
    

    
    J Pediatr Surg

33. HONG SK, Yi NJ, Chang H, Ahn SW, et al
    The rate of hepatic artery complications is higher in pediatric liver transplant recipients with metabolic liver diseases than with biliary atresia.
    J Pediatr Surg. 2018 Apr 27. pii: S0022-3468(18)30275.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

34. GARCIA-TSAO G
    Long-term albumin in cirrhosis: is it the ANSWER?
    Lancet. 2018 May 31. pii: S0140-6736(18)30948.
    PubMed     Text format    
    
    
35. CARACENI P, Riggio O, Angeli P, Alessandria C, et al
    Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
    Lancet. 2018 May 31. pii: S0140-6736(18)30840.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Oncol

36. PERSONENI N, Rimassa L
    Shaping the landscape of immune oncology in hepatocellular carcinoma.
    Lancet Oncol. 2018 Jun 1. pii: S1470-2045(18)30383.
    PubMed     Text format    
    
    
37. ZHU AX, Finn RS, Edeline J, Cattan S, et al
    Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial.
    Lancet Oncol. 2018 Jun 1. pii: S1470-2045(18)30351.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

38. KANDA M, Tanaka H, Shimizu D, Miwa T, et al
    SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells.
    Oncogene. 2018 Jun 1. pii: 10.1038/s41388-018-0335.
    PubMed     Text format     Abstract available
    
    

    
    Radiology

39. JOO I, Lee JM, Yoon JH
    Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges.
    Radiology. 2018 Jun 5:171187. doi: 10.1148/radiol.2018171187.
    PubMed     Text format     Abstract available
    
    

    
    Semin Liver Dis

40. DOU L, Ono Y, Chen YF, Thomson AW, et al
    Hepatic Dendritic Cells, the Tolerogenic Liver Environment, and Liver Disease.
    Semin Liver Dis. 2018;38:170-180.
    PubMed     Text format     Abstract available
    
    
41. RIMBAS M, Di Maurizio L, Rizzatti G, Gasbarrini A, et al
    Endoscopic Ultrasound for the Hepatologist: A Comprehensive Review.
    Semin Liver Dis. 2018;38:145-159.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: